Fatty acid binding protein 4 in circulating leucocytes reflects atherosclerotic lesion progression in Apoe-/- mice

Journal of Cellular and Molecular Medicine

Volumn 17, Issue 2, 2013, Pages 303-310

  Agardh, Hanna E ^a   Gertow, Karl ^a   Salvado, Dolores M ^a   Hermansson, Andreas ^a   van Puijvelde, Gijs H ^b   Hansson, Göran K ^a   n Berne, Gabrielle Paulsso ^a   Gabrielsen, Anders ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Atherosclerosis; Biomarkers; Leucocytes

Indexed keywords

APOLIPOPROTEIN E; BIOLOGICAL MARKER; FABP4 PROTEIN, HUMAN; FABP4 PROTEIN, MOUSE; FATTY ACID BINDING PROTEIN; MESSENGER RNA;

ANIMAL; ARTICLE; ATHEROSCLEROSIS; C57BL MOUSE; DISEASE COURSE; DNA MICROARRAY; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION PROFILING; GENETICS; HUMAN; KNOCKOUT MOUSE; LEUKOCYTE; MACROPHAGE; METABOLISM; MONOCYTE; MOUSE; PATHOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; DISEASE PROGRESSION; FATTY ACID-BINDING PROTEINS; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION PROFILING; HUMANS; LEUKOCYTES; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MONOCYTES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84874362540     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12011     Document Type: Article

References (30)

1. Ross R. The pathogenesis of the atherosclerosis: a perspective for the 1990s. Nature. 1993; 362: 801-9.
2. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005; 352: 1685-95.
3. Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol. 2011; 12: 204-12.
4. Libby P, Ridker PM. Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. Am J Med. 2004; 116: 9S-16S.
5. Scirica BM, Morrow DA. Is C-reactive protein an innocent bystander or proatherogenic culprit? The verdict is still out. Circulation. 2006; 113: 2128-34.
6. Packard RR, Libby P. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem. 2008; 54: 24-38.
7. Eagle KA, Ginsburg GS, Musunuru K, et al. Identifying patients at high risk of a cardiovascular event in the near future: current status and future directions: report of a national heart, lung, and blood institute working group. Circulation. 2010; 121: 1447-54.
8. Makowski L, Boord JB, Maeda K, et al. Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat Med. 2001; 7: 699-705.
9. Boord JB, Maeda K, Makowski L, et al. Combined adipocyte-macrophage fatty acid-binding protein deficiency improves metabolism, atherosclerosis, and survival in apolipoprotein E-deficient mice Circulation. 2004; 110: 1492-8.
10. Makowski L, Brittingham KC, Reynolds JM, et al. The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor gamma and IkappaB kinase activities. J Biol Chem. 2005; 280: 12888-95.
11. Furuhashi M, Tuncman G, Gorgun CZ, et al. Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature. 2007; 447: 959-65.
12. Hertzel AV, Bernlohr DA. The mammalian fatty acid-binding protein multigene family: molecular and genetic insights into function. Trends Endocrinol Metab. 2000; 11: 175-80.
13. Furuhashi M, Hotamisligil GS. Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov. 2008; 7: 489-503.
14. Rolph MS, Young TR, Shum BO, et al. Regulation of dendritic cell function and T cell priming by the fatty acid-binding protein AP2. J Immunol. 2006; 177: 7794-801.
15. Agardh HE, Folkersen L, Ekstrand J, et al. Expression of fatty acid-binding protein 4/aP2 is correlated with plaque instability in carotid atherosclerosis. J Intern Med. 2011; 269: 200-10.
16. Peeters W, de Kleijn DP, Vink A, et al. Adipocyte fatty acid binding protein in atherosclerotic plaques is associated with local vulnerability and is predictive for the occurrence of adverse cardiovascular events. Eur Heart J. 2011; 32: 1758-68.
17. Saksi J, Ijas P, Nuotio K, et al. Gene expression differences between stroke-associated and asymptomatic carotid plaques. J Mol Med. 2011; 89: 1015-26.
18. Cheng F, Keeley E, Lee J. Molecular prediction for atherogenic risks across different cell types of leukocytes. BMC Med Genomics. 2012; 5: 2. doi: 10.1186/1755-8794-5-2.
19. Borgeat P, Hamberg M, Samuelsson B. Transformation of arachidonic acid and homo-gamma-linolenic acid by rabbit polymorphonuclear leukocytes. Monohydroxy acids from novel lipoxygenases. J Biol Chem. 1976; 251: 7816-20.
20. Zimmer JS, Dyckes DF, Bernlohr DA, et al. Fatty acid binding proteins stabilize leukotriene A4: competition with arachidonic acid but not other lipoxygenase products. J Lipid Res. 2004; 45: 2138-44.
21. Weber C, Zernecke A, Libby P. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat Rev Immunol. 2008; 8: 802-15.
22. Soehnlein O, Weber C. Myeloid cells in atherosclerosis: initiators and decision shapers. Semin Immunopathol. 2009; 31: 35-47.
23. -/- Mice. Am J Pathol. 2010; 177: 493-500.
24. Drechsler M, Megens RT, van Zandvoort M, et al. Hyperlipidemia-triggered neutrophilia promotes early atherosclerosis. Circulation. 2010; 122: 1837-45.
25. Zernecke A, Bot I, Djalali-Talab Y, et al. Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis. Circ Res. 2008; 102: 209-17.
26. Soehnlein O, Lindbom L. Phagocyte partnership during the onset and resolution of inflammation. Nat Rev Immunol. 2010; 10: 427-39.
27. Randolph GJ. The fate of monocytes in atherosclerosis. J Thromb Haemost. 2009; 7: 28-30.
28. Swirski FK, Libby P, Aikawa E, et al. Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J Clin Invest. 2007; 1197: 195-205.
29. Ionita MG, van den Borne P, Catanzariti LM, et al. High neutrophil numbers in human carotid atherosclerotic plaques are associated with characteristics of rupture-prone lesions. Arterioscler Thromb Vasc Biol. 2010; 30: 1842-8.
30. Tavora FR, Ripple M, Li L, et al. Monocytes and neutrophils expressing myeloperoxidase occur in fibrous caps and thrombi in unstable coronary plaques. BMC Cardiovasc Disord. 2009; 9: 27.